Literature
Home医源资料库在线期刊微生物临床杂志2005年第43卷第3期

Multiplex Real-Time PCR Assay Using Scorpion Probes and DNA Capture for Genotype-Specific Detection of Giardia lamblia on Fecal Samples

来源:微生物临床杂志
摘要:DivisionofInfectiousDiseasesandInternationalHealth,UniversityofVirginia,Charlottesville,VirginiaCentreforHealthandPopulationResearch,InternationalCentreforDiarrhoealDiseaseResearch,Bangladesh,Dhaka,BangladeshABSTRACTTwomajorgenotypicassemblagesofGiardialambliain......

点击显示 收起

    Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia
    Centre for Health and Population Research, International Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka, Bangladesh

    ABSTRACT

    Two major genotypic assemblages of Giardia lamblia infect humans; the epidemiologic significance of this phenomenon is poorly understood. We developed a single-vessel multiplex real-time PCR (qPCR) assay that genotypes Giardia infections into assemblages A and/or B directly from fecal samples. The assay utilized Scorpion probes that combined genotype-specific primers and probes for the 18S rRNA gene into the same molecule. The protocol was capable of detecting as few as 20 trophozoites per PCR on fecal DNA isolated using a commercial method or 1.25 trophozoites per PCR on fecal DNA isolated using a G. lamblia-specific oligonucleotide capture technique. The assay was specific for fecal specimens, with no amplification of the discordant genotype with the opposite Scorpion probe. When 97 clinical specimens from Bangladesh were used, the multiplex PCR assay detected 95% (21 of 22) of Giardia microscopy-positive specimens and 18% (13 of 74) of microscopy-negative specimens. Microscopy-negative and qPCR-positive specimens had higher average cycle threshold values than microscopy-positive and qPCR-positive specimens, suggesting that they represented true low-burden infections. Most (32 of 35) infections were assemblage B infections. This single-reaction multiplex qPCR assay distinguishes assemblage A Giardia infections from assemblage B infections directly on fecal samples and may aid epidemiologic investigation.

    INTRODUCTION

    Members of the genus Giardia are the most commonly diagnosed intestinal parasites in the United States and cause approximately 200 million clinical infections per year worldwide (7). The genus can be distinguished on the basis of morphology, ultrastructural features, or 18S rRNA sequence into at least six species, G. lamblia (synonymous with G. duodenalis or G. intestinalis), G. agilis, G. muris, G. ardeae, G. psittaci, and G. microti (17). Isolates of G. lamblia have been further subgrouped by alloenzyme or sequence analysis of the glutamate dehydrogenase, triose phosphate isomerase, elongation factor 1, 18S rRNA, and other genes. Depending on the assay, G. lamblia subgroup nomenclature has included Nash groups 1 to 3 (19), genotype "Poland" versus "Belgium" (12), and assemblages A and B with subgroups A-I, A-II, B-III, and B-IV (16). Despite the complicated terminology, phylogenetic sequence analysis of the independent genetic loci has provided essentially concordant results showing that there are two major G. lamblia groups which cause human infection (14, 17). Use of the assemblage A and B nomenclature for these two main groups has been proposed, and we will adopt it hereafter for convenience.

    While the genotypic separation of G. lamblia assemblages is relatively well established, the clinical or epidemiologic significance of infection with assemblage A versus B is poorly understood. One report from Mexico (6) indicated that 11 isolates were assemblage A type, while another from Canada indicated that 12 of 15 clinical specimens were assemblage B type (9). Similarly small studies from India and Australia resulted in reports that assemblage A was associated with symptomatic infection relative to assemblage B (20, 22). In contrast, a correlation between assemblage B and persistent diarrheal symptoms was observed in The Netherlands (11).

    More complete data on the epidemiology of infection with individual Giardia genotypes may enhance the clinical significance of detection and aid outbreak investigation. Existing diagnostic methods for use on human feces such as microscopy and enzyme-linked immunosorbent assay (ELISA) do not discriminate between the two assemblages. Genotype-specific PCR or PCR-restriction fragment length polymorphism has been performed by several investigators (3, 5, 10, 18) but is a time-consuming two-step procedure subject to contamination. Several real-time PCR (qPCR) assays for Giardia have subsequently been published (4, 8, 26, 27), including three that are capable of genotyping (2, 9, 13); however, most require multiple reactions, and details on assay sensitivity are unclear. Lastly, an assay using multiplex PCR and microarray hybridization has been published; however, that assay used only cultured trophozoites (28). We therefore sought to develop a qPCR assay utilizing self-probing amplicon primers (30) that would distinguish assemblages A and B in a single reaction and that was sufficiently sensitive for high-throughput use directly on human fecal samples.

    MATERIALS AND METHODS

    Spiking of fecal samples. Giardia lamblia lines WB and GS (assemblage A-group 1 and assemblage B-group 3, respectively; provided by Steven Singer, Georgetown University, and Rodney Adam, University of Arizona) were cultured axenically in TY-S-33 medium at 37°C. Trophozoites were counted in a hemocytometer, sedimented, washed in sterile phosphate-buffered saline (PBS), and spiked into 200-mg aliquots of parasite-free stool as indicated.

    Human fecal specimens. Stool specimens were obtained from individuals with diarrhea at the International Centre for Diarrheal Diseases and Research, Dhaka, Bangladesh. Informed consent was obtained from the parents or guardians of all participants, and the human experimentation guidelines of the U.S. Department of Health and Human Services, the University of Virginia, and the Centre for Health and Population Research, International Centre for Diarrheal Disease Research, Bangladesh, were followed in the conduct of this research. All specimens were tested for Giardia infection by saline wet-mount microscopy after staining with Lugol's iodine. PCR-positive specimens were additionally tested using a Giardia II kit (Techlab, Blacksburg, Va.) for detection of Giardia antigen per the manufacturer's instructions.

    DNA extraction. DNA was extracted from spiked stool samples and human fecal specimens both by the commercial QIAamp method and by DNA capture. For the QIAamp method, fecal specimens were washed twice with sterile PBS and centrifuged for 5 min at 18,000 x g; the fecal pellet was then subjected to six cycles of freeze-thaw in liquid nitrogen and a 95°C water bath. DNA was then extracted using a QIAamp DNA Stool Mini kit (QIAGEN, Valencia, Calif.) per the manufacturer's instructions except that the suspension was incubated in the kit's stool lysis buffer at 95°C and a 3-min incubation with InhibitEx tablets was performed. Genomic DNA of G. lamblia, Entamoeba histolytica, E. dispar, E. moshkovskii, and Cryptosporidium parvum was obtained by this method using pure trophozoite or oocyst pellets. For sequence-specific DNA capture, fecal samples were processed according to the protocol of Shuber et al. (23). Briefly, 200 mg of spiked stool was homogenized in 1.4 ml of EXACT Buffer A (Exact Sciences Corporation, Marlborough, Mass.) and centrifuged twice for 20 min at 18,000 x g. The supernatant was treated with 10 ng of RNase and DNA precipitated with 300 mM sodium acetate and isopropanol. DNA was then resuspended in 200 μl of TE buffer (10 mM Tris, 1 mM EDTA, pH 7.4), incubated at 95°C for 10 min, cooled on ice, and then incubated at 25°C for 4 h in an equal volume of 6 M guanidine thiocyanate and 200 pmol of biotinylated oligonucleotide 5'-GCTAGCCGGACACCGCTGGCAAC-3', a sequence that is common to both assemblage A and B (see accession numbers below) and is downstream from the PCR amplicon (Fig. 1A). This suspension was then incubated for 1 h at room temperature with streptavidin-coated MagneSphere Paramagnetic Particles (Promega, Madison, Wis.). Bead-DNA complexes were washed three times in buffer (1 M NaCl, 0.01 M Tris-HCl, 1 mM EDTA, 0.1% Tween 20, pH = 7.4) and incubated at 85°C for 10 min in 50 μl of 10 mM Tris (pH = 7.0).

    Oligonucleotides. We reviewed the literature that grouped human G. lamblia isolates by 18S rRNA sequence into assemblages A and B (25), assemblage A and B subgroups I to IV (17), and groups 1 to 3 (29) and obtained the following sequences from the National Center for Biotechnology Information database: for assemblage A, AF199446, M54878, X52949, and AY130269 to AY130281; for assemblage B, AF113897, AF113898, AF199447, and U09492, which encompass subgroups A-I (M54878), A-II (X52949), B-III (AF113897), and B-IV (AF113898). Sequences were aligned using Clustal X version 1.8 (24; http://www.ebi.ac.uk/clustalw/). Assemblage A-specific forward primer AF (5'-ATCCTGCCGGAGCGCGACG-3') and assemblage B-specific forward primer BF (5'-CGGTCGATCCTGCCGGAATC-3') (similar to those used by Johnson et al.) (13) were paired with the reverse primer R3 (5'-GGGGTGCAACCGTTGTCCT-3') (common to both assemblage A and B sequences) to produce 95- and 102-bp products, respectively (Fig. 1A). Primers demonstrated no deleterious secondary structures, and no significant identity (E < 1.0) to non-Giardia sequences was found by a BLAST search (1; http://www.ncbi.nlm.nih.gov/BLAST/). Scorpion Uni-probes (Proligo, Paris, France) specific for assemblage A and assemblage B sequences were designed, whereby a 5' reporter dye, a specific stem-loop sequence, a black-hole quencher (BHQ1), and a hexethylene glycol (HEG) reverse-extension blocker were linked to the above-mentioned forward primers as follows: for ScA, hexachloro-6-carboxyfluorescein (HEX)CCCGGCGCATGGCTTCGTCCTTGCCGGG-BHQ1-HEG-ATCCTGCCGGAGCGCGACG; for ScB, 6-carboxyfluorescein (FAM)-CGGGCATGCATGGCCCG-BHQ1-HEG-CGGTCGATCCTGCCGGAATC. Underlined sequences indicate the regions of the stem-loop sequence that are complementary to the neosynthesized strand (Fig. 1B and C). Of note, ScA aligns with Nash group 1 sequence (the Portland-1 strain, M54878); however, detection of groups 2 and 3 cannot be determined, insofar as the group 2 and 3 18S rRNA sequences described by Weiss et al. are short (183-bp) fragments downstream from and not inclusive of our amplicon (29).

    PCR amplification. Singleplex amplifications took place in 25-μl reaction mixtures containing 1x PCR buffer (QIAGEN), 3.5 mM total MgCl2 (including that contained in the PCR buffer), 0.5 mM (each) deoxynucleoside triphosphates (dNTPs), 1.25 U of Taq polymerase (HotStarTaq; QIAGEN), 6% dimethyl sulfoxide (DMSO), 50 μg of bovine serum albumin (BSA), 7.44 pmols of Scorpion probe and reverse primer, and 5 μl of fecally extracted DNA. Multiplex reactions were performed in 25-μl volumes with 1x PCR buffer, 4.0 mM total MgCl2 (including that contained in the PCR buffer), 1.0 mM dNTPs, 2.5 U of Taq polymerase (HotStarTaq; QIAGEN), 6% DMSO, 50 μg of BSA, 7.44 pmols of each Scorpion probe and reverse primer, and 5 μl of fecally extracted DNA. Amplification was performed on an iCycler (Bio-Rad, Hercules, Calif.) under the following cycling conditions: 95°C for 15 min and then 40 cycles of 94°C for 20 s and 60°C for 30 s. Amplification was confirmed in all reactions by gel electrophoresis; therefore, a 5-min 72°C incubation was added at the end of the cycling protocol.

    Statistics. Values for the average threshold of qPCR amplification (cycle threshold [CT]) were compared between microscopy-positive and microscopy-negative groups by the Mann-Whitney test. The nonparametric Spearman correlation was used to quantitate the degree of association between ELISA optical density and CT on ELISA-positive and qPCR-positive specimens.

    RESULTS

    Sensitivity of singleplex qPCR. The sensitivity of the assay using the QIAamp extraction method to detect G. lamblia DNA in stool was 20 trophozoites per reaction for assemblage A (CT = 37.4) and 200 trophozoites per reaction for assemblage B (CT = 35.0) (Fig. 2). Sensitivity was increased with the addition of BSA and DMSO and was not enhanced by dilution of the DNA samples (data not shown), suggesting that the DNA yield was limiting as opposed to PCR inhibition. We therefore utilized a DNA extraction method involving sequence-specific gene capture of a downstream region of the 18S rRNA gene conserved between assemblages (Fig. 1A). DNA obtained by this method amplified at least 16-fold more efficiently than the QIAamp extraction procedure (equal or greater fluorescence at 1.25 versus 20 trophozoites/reaction for assemblage A and 12.5 versus 200 trophozoites/reaction for assemblage B; Fig. 1).

    Specificity of singleplex qPCR. The specificity of the assemblage A- and B-specific Scorpion probes was tested on genomic DNA from G. lamblia assemblages A and B as well as on DNA isolated from stool samples spiked with up to 20,000 assemblage A or B trophozoites per reaction. No amplification was detected by qPCR or gel electrophoresis on discordantly spiked stool samples, regardless of parasite concentration or the method of DNA extraction (data not shown). Amplification of the discordant G. lamblia assemblage was only observed when pure genomic DNA (9.9 x 105 trophozoites/reaction) was used; such amplification was extremely inefficient, yielding a CT equivalent to that obtained using 30 trophozoites of the concordant assemblage/reaction (data not shown). No amplification was observed with either Scorpion probe upon using genomic DNA of E. histolytica, E. dispar, E. moshkovskii, or Cryptosporidium parvum (data not shown).

    Multiplex PCR. The two singleplex assays were combined to create a single-tube multiplex assay for use with human stool samples (Fig. 3). The test was specific, with no FAM fluorescence observed with assemblage A-spiked fecal samples (Fig. 3A) and no HEX fluorescence observed using B-spiked fecal samples (Fig. 3B). Sensitivity remained at the level of the singleplex assays after optimization for magnesium, dNTP, and Taq polymerase concentrations per procedures described above in Materials and Methods, and CT levels were not diminished in coinfected versus monoinfected specimens (Fig. 3C versus 3A or 3B).

    Comparison of multiplex PCR with microscopy for human clinical specimens. Samples of 97 human stool specimens from diarrheal patients at the International Centre for Diarrheal Diseases, Bangladesh, were tested by saline wet-mount microscopy and by the qPCR assay using DNA extracted by the QIAamp method (Table 1). For confirmation, three of the PCR products (two from assemblage B and one from assemblage A) were sequenced and revealed complete identity to the published sequence (Fig. 1). The multiplex qPCR assay demonstrated 85% (83 of 97 samples) agreement with microscopy. The one microscopy-positive and qPCR-negative specimen was unavailable for additional testing; however, the microscopy-negative and qPCR-positive specimens were retested by ELISA, and 69% (9 of 13) were ELISA positive. Additionally, the microscopy-negative and qPCR-positive specimens had delayed CT values versus the microscopy-positive and qPCR-positive specimens (35.3 ± 4.5 versus 33.0 ± 3.6; P = 0.04), further suggesting that the microscopy-negative and qPCR-positive specimens represented low-burden true infections. Finally, all available qPCR-positive specimens were retested by ELISA; 88% (30 of 34) were ELISA positive, and qPCR CT values exhibited the expected inverse correlation with ELISA optical density values (correlation coefficient = –0.44; P = 0.01 by Spearman correlation test [n = 30]). Accordingly, with qPCR as the "gold standard," microscopic examination exhibited 98% specificity and only 62% sensitivity.

    DISCUSSION

    This work details the development of a novel real-time PCR assay that genotypes Giardia infections from fecal specimens in a single closed-tube reaction. The test is specific and sensitive to well below the estimated parasite excretion rate in humans of 150 to 20,000 cysts/gram of stool (21). The assay can test 96 samples in 2 h and thus provides the capacity to characterize the Giardia genotype for large numbers of asymptomatic and symptomatic individuals from various geographic locations. Such epidemiologic data are presently limited but may ultimately enhance the ability to prognosticate an individual's course of infection and investigate source outbreaks.

    We utilized Scorpion probes (30) instead of hydrolysis probes, hybridization probes, molecular beacons, or SYBR Green I. Although SYBR Green I was used for assay development (data not shown), we felt that the nonspecific fluorescence of an intercalating dye would be unacceptable given the complexity of fecally extracted DNA and our desire to multiplex. A published hydrolysis probe-based assay (13) was tried during early development; however, this TaqMan probe did not allow discrimination of genotypes and required a longer amplicon, which decreased amplification sensitivity (data not shown). Furthermore, in practice we found that genotype-specific design of TaqMan probes, hybridization probes, or molecular beacons was complicated by the high G-C content (75%) of the Giardia 18S rRNA gene, its frequent runs of guanines, and the few nucleotide polymorphisms between assemblages. Moreover, these bi- or trimolecular reactions increase the possibility of primer-probe dimerization or nonspecific binding to DNA template and impose temperature constraints on the kinetics of hybridization, all of which would be magnified upon multiplexing.

    Scorpion probes are unimolecular and yet can maintain a dual layer of specificity when both primer and probe are genotype specific. The primers we chose were specific for assemblage A and B isolates, including subgroups A-I and -II and B-III and -IV, according to available sequence. The primer segment of ScA contained a 3-bp mismatch to assemblage B DNA, and the probe portion took advantage of an additional 2-bp assemblage A-specific change. This dual layer of specificity ensured that falsely primed products would not lead to fluorescence detection. Sufficient specificity and sensitivity was achieved with an ScB Scorpion probe, with only a 3-bp mismatch at the primer 3' end, so a B-specific sequence was not required in the probe region. An additional layer of specificity to the PCR was added by utilization of a sequence-specific oligonucleotide to capture our DNA of interest. This DNA-capture technique (23) increased sensitivity at least 16-fold versus the results seen with the widely used commercial QIAamp stool kit, presumably due to increased target DNA yield. We used a proprietary lysis buffer for this method; however, others have performed the same technique with conventional reagents (15). On the same note, the multiplex Scorpion PCR can be rapidly cooled to 30°C for endpoint analysis on a fluorescent plate reader, obviating the expense of a real-time PCR machine. These are important concerns, as the assay should be as inexpensive as possible for the regions of the world where Giardia is highly endemic.

    The test performed favorably with human diarrheal specimens and detected 60% more infections than microscopy alone. While there is no perfect gold standard test for enteric infections, we suspect that these microscopy-negative and qPCR-positive specimens were true infections given their high rate of ELISA positivity and relatively delayed CT. The specimens were from a cohort of children with diarrhea in Mirpur, Bangladesh, and most (91%) were assemblage B infections. This majority is similar to the 70 to 80% rates of assemblage B infection observed in Australia (22) and Canada (9) but contrasts with reports from Mexico (6), India (20), and China (31), which have indicated equal or higher assemblage A infection rates. It is important to emphasize that the reported studies were small and uncontrolled and that some used cultivated trophozoites as opposed to direct fecal testing. As such, we will await larger studies, and this is the rationale for developing this multiplex assay.

    ACKNOWLEDGMENTS

    This work was supported by Public Health Service grant AI-056872 and AI-043596 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, the Carilion Biomedical Institute, and the Commonwealth Technology Research Fund.

    We thank Steven Powell for guidance, Tony Schuber for provision of Exact Buffer A (Exact Sciences Corporation, Marlborough, Mass.), and William A. Petri, Jr., for helpful discussions.

    Present address: Spelman University, Atlanta, GA 30314.

    REFERENCES

    Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.

    Amar, C. F., P. H. Dear, and J. McLauchlin. 2003. Detection and genotyping by real-time PCR/RFLP analyses of Giardia duodenalis from human faeces. J. Med. Microbiol. 52:681-683.

    Amar, C. F., P. H. Dear, S. Pedraza-Diaz, N. Looker, E. Linnane, and J. McLauchlin. 2002. Sensitive PCR-restriction fragment length polymorphism assay for detection and genotyping of Giardia duodenalis in human feces. J. Clin. Microbiol. 40:446-452.

    Bertrand, I., C. Gantzer, T. Chesnot, and J. Schwartzbrod. 2004. Improved specificity for Giardia lamblia cyst quantification in wastewater by development of a real-time PCR method. J. Microbiol. Methods 57:41-53.

    Caccio, S. M., M. De Giacomo, and E. Pozio. 2002. Sequence analysis of the beta-giardin gene and development of a polymerase chain reaction-restriction fragment length polymorphism assay to genotype Giardia duodenalis cysts from human faecal samples. Int. J. Parasitol. 32:1023-1030.

    Cedillo-Rivera, R., J. M. Darby, J. A. Enciso-Moreno, G. Ortega-Pierres, and P. L. Ey. 2003. Genetic homogeneity of axenic isolates of Giardia intestinalis derived from acute and chronically infected individuals in Mexico. Parasitol. Res. 90:119-123.

    Furness, B. W., M. J. Beach, and J. M. Roberts. 2000. Giardiasis surveillance—United States, 1992-1997. Morb. Mortal. Wkly. Rep. Surveill. Summ. 49:1-13.

    Guy, R. A., P. Payment, U. J. Krull, and P. A. Horgen. 2003. Real-time PCR for quantification of Giardia and Cryptosporidium in environmental water samples and sewage. Appl. Environ. Microbiol. 69:5178-5185.

    Guy, R. A., C. Xiao, and P. A. Horgen. 2004. Real-time PCR assay for detection and genotype differentiation of Giardia lamblia in stool specimens. J. Clin. Microbiol. 42:3317-3320.

    Homan, W. L., M. Gilsing, H. Bentala, L. Limper, and F. van Knapen. 1998. Characterization of Giardia duodenalis by polymerase-chain-reaction fingerprinting. Parasitol. Res. 84:707-714.

    Homan, W. L., and T. G. Mank. 2001. Human giardiasis: genotype linked differences in clinical symptomatology. Int. J. Parasitol. 31:822-826.

    Homan, W. L., F. H. van Enckevort, L. Limper, G. J. van Eys, G. J. Schoone, W. Kasprzak, A. C. Majewska, and F. van Knapen. 1992. Comparison of Giardia isolates from different laboratories by isoenzyme analysis and recombinant DNA probes. Parasitol. Res. 78:316-323.

    Johnson, M. L., D. I. Berryman, J. A. Reynoldson, and R. C. Thompson. 2003. A fluorescent based PCR assay for the detection and quantitation of Giardia duodenalis genotypes in mixed populations. Infect. Genet. Evol. 3:97-102.

    Lu, S. Q., A. C. Baruch, and R. D. Adam. 1998. Molecular comparison of Giardia lamblia isolates. Int. J. Parasitol. 28:1341-1345.

    MacKay, W. G., C. L. Williams, M. McMillan, R. N. Ndip, A. J. Shepherd, and L. T. Weaver. 2003. Evaluation of protocol using gene capture and PCR for detection of Helicobacter pylori DNA in feces. J. Clin. Microbiol. 41:4589-4593.

    Mayrhofer, G., R. H. Andrews, P. L. Ey, and N. B. Chilton. 1995. Division of Giardia isolates from humans into two genetically distinct assemblages by electrophoretic analysis of enzymes encoded at 27 loci and comparison with Giardia muris. Parasitology 111:11-17.

    Monis, P. T., R. H. Andrews, G. Mayrhofer, and P. L. Ey. 1999. Molecular systematics of the parasitic protozoan Giardia intestinalis. Mol. Biol. Evol. 16:1135-1144.

    Monis, P. T., G. Mayrhofer, R. H. Andrews, W. L. Homan, L. Limper, and P. L. Ey. 1996. Molecular genetic analysis of Giardia intestinalis isolates at the glutamate dehydrogenase locus. Parasitology 112:1-12.

    Nash, T. E., T. McCutchan, D. Keister, J. B. Dame, J. D. Conrad, and F. D. Gillin. 1985. Restriction-endonuclease analysis of DNA from 15 Giardia isolates obtained from humans and animals. J. Infect. Dis. 152:64-73.

    Paintlia, A. S., R. C. Mahajan, A. Chakraborti, R. Sehgal, and N. K. Ganguly. 1999. Characterization of Giardia lamblia groups A and B from North India by isoenzyme and random amplified polymorphic DNA analysis. Parasitol. Res. 85:510-512.

    Porter, A. 1916. An enumerative study of the cysts of Giardia (lamblia) intestinalis in human dysenteric faeces. Lancet i:1166-1169.

    Read, C., J. Walters, I. D. Robertson, and R. C. Thompson. 2002. Correlation between genotype of Giardia duodenalis and diarrhoea. Int. J. Parasitol. 32:229-231.

    Shuber, A. P., J. J. Ascano, K. A. Boynton, A. Mitchell, H. F. Frierson, Jr., W. El-Rifai, and S. M. Powell. 2002. Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment. J. Clin. Microbiol. 40:262-264.

    Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.

    Thompson, R. C., R. M. Hopkins, and W. L. Homan. 2000. Nomenclature and genetic groupings of Giardia infecting mammals. Parasitol. Today 16:210-213.

    Verweij, J. J., R. A. Blange, K. Templeton, J. Schinkel, E. A. Brienen, M. A. van Rooyen, L. van Lieshout, and A. M. Polderman. 2004. Simultaneous detection of Entamoeba histolytica, Giardia lamblia, and Cryptosporidium parvum in fecal samples by using multiplex real-time PCR. J. Clin. Microbiol. 42:1220-1223.

    Verweij, J. J., J. Schinkel, D. Laeijendecker, M. A. van Rooyen, L. van Lieshout, and A. M. Polderman. 2003. Real-time PCR for the detection of Giardia lamblia. Mol. Cell. Probes 17:223-225.

    Wang, Z., G. J. Vora, and D. A. Stenger. 2004. Detection and genotyping of Entamoeba histolytica, Entamoeba dispar, Giardia lamblia, and Cryptosporidium parvum by oligonucleotide microarray. J. Clin. Microbiol. 42:3262-3271.

    Weiss, J. B., H. van Keulen, and T. E. Nash. 1992. Classification of subgroups of Giardia lamblia based upon ribosomal RNA gene sequence using the polymerase chain reaction. Mol. Biochem. Parasitol. 54:73-86.

    Whitcombe, D., J. Theaker, S. P. Guy, T. Brown, and S. Little. 1999. Detection of PCR products using self-probing amplicons and fluorescence. Nat. Biotechnol. 17:804-807.

    Yong, T. S., S. J. Park, U. W. Hwang, H. W. Yang, K. W. Lee, D. Y. Min, H. J. Rim, Y. Wang, and F. Zheng. 2000. Genotyping of Giardia lamblia isolates from humans in China and Korea using ribosomal DNA sequences. J. Parasitol. 86:887-891.

作者: Cherie T. Ng, Carol A. Gilchrist, Ariel Lane, Shan 2007-5-10
医学百科App—中西医基础知识学习工具
  • 相关内容
  • 近期更新
  • 热文榜
  • 医学百科App—健康测试工具